Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

M Cavo, F Gay, M Beksac, L Pantani, MT Petrucci, MA Dimopoulos, Ronnie van der Holt, Vincent van der Velden, A. Broijl, M Boccadoro, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E456-E468
JournalLancet Haematology
Issue number6
Publication statusPublished - 2020

Cite this